Περίληψη:
Radiation-induced breast sarcomas (RIBS) are rare entities representing <1% of all primary breast malignancies, limiting most reports to small retrospective case series. They constitute a heterogeneous group of neoplasms, with high-grade angiosarcoma being the most common sub-type. Other sarcoma histotypes, such as undifferentiated pleomorphic sarcoma and leiomyosarcoma, can also be identified. Radiation-induced breast angiosarcoma (RIBA) has an incidence of approximately 0.1% after breast-conserving therapy and arises mainly from the dermis of the irradiated breast. MYC gene amplification is highly indicative of secondary breast angiosarcomas. Their clinical presentation often mimics benign port-radiation lesions, leading to a delay in diagnosis and a lost window of opportunity for cure. Surgery with negative margins is the mainstay of treatment of localized RIBS. In the case of angiosarcoma, technical difficulties, including multifocality, infiltrative margins, and difficulty in assessing tumor margins, render surgical treatment quite challenging. A limited number of studies showed that adjuvant radiation therapy reduces local recurrences; therefore, it is proposed by many groups for large, high-grade tumors. Chemotherapy has been evaluated retrospectively in a small subset of patients, with some evidence supporting its use in angiosarcoma patients. Approximately half of patients with RIBA will show local recurrence. In the advanced setting, different therapeutic options are discussed in the review, including chemotherapy, antiangiogenic therapy, and immunotherapy, whereas the need for further research on molecular therapeutic targets is pointed out. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Συγγραφείς:
Kokkali, S.
Moreno, J.D.
Klijanienko, J.
Theocharis, S.
Λέξεις-κλειδιά:
bevacizumab; immunological antineoplastic agent; protein tyrosine kinase inhibitor, adjuvant chemotherapy; angiosarcoma; antiangiogenic therapy; breast carcinogenesis; breast sarcoma; cancer chemotherapy; cancer immunotherapy; cancer prognosis; cancer radiotherapy; cancer surgery; clinical feature; gene mutation; histology; human; inoperable cancer; metastasis; neoadjuvant chemotherapy; overall survival; pathophysiology; patient selection; radiation induced cancer; Review; surgical margin; angiosarcoma; breast tumor; female; genetics; radiation induced neoplasm; retrospective study; sarcoma; soft tissue tumor, Breast Neoplasms; Female; Hemangiosarcoma; Humans; Margins of Excision; Neoplasms, Radiation-Induced; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms
